Skip to main content
. 2019 Mar 11;9(4):e01254. doi: 10.1002/brb3.1254

Figure 2.

Figure 2

Glibenclamide decreases intracerebral hemorrhage (ICH)‐induced cytokine amplification. mRNA levels of interleukin (IL)‐1β, IL‐18, IL‐6, and tumor necrosis factor (TNF)‐α in brain tissue 3 days after ICH (n = 4 in sham group, n = 6 in ICH group, *p < 0.05, ** p < 0.01).